Introducing —GC Wellbeing’s Safe Medicine.
Characteristics | Brown ampoule injection that contains colorless to pale-yellow liquid. |
---|---|
Full Ingredient | Active ingredient in 1mL: 0.2g of L-carnitine |
Efficacy/Effect |
1) Primary and secondary carnitine deficiency 2) Myocardial metabolic disorders due to ischemic heart disease: angina pectoris, acute myocardial infarction 3) Treatment of carnitine deficiency in end-stage renal disease patients undergoing hemodialysis |
Usage/Dosage |
1) Primary and secondary carnitine deficiency Myocardial metabolic disorders due to ischemic heart disease: angina pectoris, acute myocardial infarction Adults: Intramuscular injection or IV drip of 2~3g L-carnitine per day, divided into 2 or 3 doses. Increase or decrease the administered amount according to age and symptoms. 2) Treatment of carnitine deficiency in end-stage renal disease patients undergoing hemodialysis Initially, 10-20mg/kg is administered intravenously over a 2?3-minute period at the end of each hemodialysis. However, the dosage can be adjusted in accordance with the plasma L-carnitine level before hemodialysis. |
Storage | Store in an opaque sealed container at room temperature (1~30℃) |
Packaging Unit | 5ml * 25amps Ampoule injection |